DEALS
Zhong Lun advises Lepu Medical's GDR Listing on the SIX Swiss Exchange
Zhong Lun advises Lepu Medical's GDR Listing on the SIX Swiss Exchange
On September 21, the Shenzhen Stock Exchange and the SIX Swiss Exchange jointly held a listing ceremony through video connection, where the global depositary receipts (GDR) issued by Lepu (Beijing) Medical Technology Co., Ltd. (“Lepu Medical") were officially listed on the SIX Swiss Exchange with a stock code of LEPU. Lepu Medical became the first GEM (Growth Enterprise Market) enterprise to be listed in Switzerland and the pioneer of GDR listing on the SIX Swiss Exchange among medical companies, setting a precedent for Chinese medical enterprises to successfully launch a fixed price issue in the Swiss market.
Zhong Lun acted as the issuer’s counsel in the listing. Tapping profound professional knowledge and years of experience, the firm rendered high-quality, rigorous and efficient legal services to Lepu Medical. Zhong Lun partners Yiwen Chen and Na Li headed the whole project, and team members also included Zhen Sun, Ben Zhao, Xuejia Pei, etc.
Lepu Medical is a platform enterprise based in China and committed to providing full life cycle services for cardiovascular patients around the world. After over 20 years of tireless endeavor in the cardiovascular field since its establishment in 1999, the company has become the first in China to commercialize domestic heart double-chamber pacemakers, coronary metal stents, coronary completely degradable stents and coronary cutting balloons, as well as the world’s first to commercialize ventricular septal fully degradable sealers and to apply artificial intelligence to ECG diagnosis. This has placed it at the forefront of the domestic cardiovascular industry.
As the first domestic medical company to list on the SIX Swiss Exchange, Lepu Medical saw its GDR warmly welcomed by overseas investment institutions. It is reported that Lepu Medical completed the GDR bookkeeping and issuance pricing in the Swiss market on September 15, and the order size exceeded the planned issuance scale by nearly five times, which far surpassed the top four Swiss market GDRs and also recent orders in the London market, illustrating the enthusiasm of overseas investors.
